Tempei Miyaji

Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial

Hironori Ishigami, Yoshiyuki Fujiwara, Ryoji Fukushima et al. · Journal of Clinical Oncology · 2018 · 356 citations

Medicine, Oncology, Pharmacology +13

The Japanese version of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE): psychometric validation and discordance between clinician and patient assessments of adverse events

Takashi Kawaguchi, Kanako Azuma, Motohiko Sano et al. · Journal of Patient-Reported Outcomes · 2018 · 250 citations · Full text

Health Professions, Oncology, Cancer Control +8

Japanese translation and linguistic validation of the US National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Tempei Miyaji, Yukiko Iioka, Yujiro Kuroda et al. · Journal of Patient-Reported Outcomes · 2017 · 209 citations · Full text

Humanities, Oncology, Translation Studies +11

Smartphone Psychotherapy Reduces Fear of Cancer Recurrence Among Breast Cancer Survivors: A Fully Decentralized Randomized Controlled Clinical Trial (J-SUPPORT 1703 Study)

Tatsuo Akechi, Takuhiro Yamaguchi, Megumi Uchida et al. · Journal of Clinical Oncology · 2022 · 76 citations · Full text

Education, Oncology, Psychology +16

Assessment of Cancer-Related Fatigue, Pain, and Quality of Life in Cancer Patients at Palliative Care Team Referral: A Multicenter Observational Study (JORTC PAL-09)

Satoru Iwase, Takashi Kawaguchi, Akihiro Tokoro et al. · PLoS ONE · 2015 · 63 citations · Full text

Medicine, Oncology, Palliative Care +13